alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Editorial Note on Part 218
Editorial Note: Nomenclature changes to part 218 appear at 68 FR 51363, Aug. 26, 2003.

§ 218.34 Investigation. ( a ) *Informal investigation.* ( 1 ) The agency will investigate complaints that are unresolved after mediation or are reopened because of a violation of a mediation agreement.
( 2 ) As part of the initial investigation, the agency will use informal fact finding methods, including joint or separate discussions with the complainant and recipient to establish the facts, and, if possible, settle the complaint on terms that are mutually agreeable. The agency may seek the assistance of any involved State agency.
( 3 ) The agency will put any agreement in writing and have it signed by the parties and an authorized official of the agency.
( 4 ) The settlement shall not affect the operation of any other enforcement efforts of the agency, including compliance reviews and other individual complaints which may involve the recipient.
( 5 ) The settlement is not a finding of discrimination against a recipient.
( b ) *Formal investigation.* If the agency cannot resolve the complaint through informal investigation, it will begin to develop formal findings through further investigation of the complaint. If the investigation indicates a violation of these regulations, the agency will attempt to obtain voluntary compliance. If the agency cannot obtain voluntary compliance, it will begin enforcement as described in § 218.36.
Exhibit 4.12





Exhibit 4.12




THIS SECOND AMENDMENT TO EMPLOYMENT AGREEMENT dated for reference the 1st day of August, 2010 (the “Amendment”).


		
	BETWEEN: 	 
	 	HELIX BIOPHARMA CORP. 
	 	(the “Company”) 
	 
	AND: 	 
	 	PHOTIOS MICHALARGIAS 
	 	(the “Executive”) 





		
	 	
WHEREAS:


	 
	
A.

	
the parties entered into an employment agreement dated for reference August 6, 2008, which was amended October 1st, 2009 (as so amended, the “Employment Agreement”);


	 
	
B.

	
the parties wish to amend the Employment Agreement, upon the terms set out in this Amendment;






THEREFORE in consideration of the recitals, the following covenants and the payment of one dollar made by each party to the other, the receipt and sufficiency of which is acknowledged by each party, the parties agree on the following terms:


		
	
1.

	
The amendments set out in this Amendment are effective on and after August 1, 2010, with the exception of the amendment to Section 3.7 of the Employment Agreement, which shall be effective June 1, 2010.


	 
	
2.

	
All other provisions of the Employment Agreement shall remain in full force and effect, except that where this Amendment may be in conflict with the provisions of the Employment Agreement, then this Amendment shall govern.


	 
	
3.

	
Section 3.1 of the Employment Agreement is deleted and replaced with the following:


	 
	 	“3.1 Annual Base Salary 
	 
	 	
The Company shall pay or provide to the Executive, for his services under this Agreement, an annual salary of $260,000, payable semi-monthly on the fifteenth and the second last banking day of the month. Should the fifteenth day of any month not be a business day, the base salary otherwise due on such date shall be paid to the Executive on the immediately preceding business day.”


	 
	
4.

	
Section 3.7 of the Employment Agreement is deleted and replaced with the following:


	 
	 	“3.7 Vacation
	 
	 	
The Executive shall be entitled to four weeks paid vacation for each fiscal year of the Company. In addition to the four weeks of paid vacation each fiscal year, the Executive shall be entitled to statutory holidays and the number of paid holidays provided for under the policies and procedures of the Company in effect from time to time. The Executive may not take in a fiscal year any of the four weeks paid vacation earned but not taken in previous fiscal years unless expressly permitted by the written policies of the Company in effect from time to time.”














- 2 -

IN WITNESS WHEREOF, the parties hereto have duly executed this Amendment as of the day and year first above written.







HELIX BIOPHARMA CORP.







Per:

/s/ Donald H. Segal

Authorized Signatory







/s/ Photios Michalargias

PHOTIOS MICHALARGIAS
### §300b–12. Laboratory quality and surveillance

#### (a) In general

The Secretary, acting through the Director of the Centers for Disease Control and Prevention and taking into consideration the expertise of the Advisory Committee on Heritable Disorders in Newborns and Children established under section 300b–10 of this title, shall provide for—

(1) quality assurance for laboratories involved in screening newborns and children for heritable disorders, including quality assurance for newborn-screening tests, timeliness for processing such tests, performance evaluation services, and technical assistance and technology transfer to newborn screening laboratories to ensure analytic validity and utility of screening tests; and

(2) appropriate quality control and other performance test materials to evaluate the performance of new screening tools.

#### (b) Surveillance activities

The Secretary, acting through the Director of the Centers for Disease Control and Prevention, and taking into consideration the expertise of the Advisory Committee on Heritable Disorders in Newborns and Children established under section 300b–10 of this title, may provide, as appropriate, for the coordination of surveillance activities, including—

(1) through standardized data collection and reporting, as well as the use of electronic health records; and

(2) by promoting data sharing regarding newborn screening with State-based birth defects and developmental disabilities monitoring programs.

(July 1, 1944, ch. 373, title XI, §1113, as added Pub. L. 110–204, §6, Apr. 24, 2008, 122 Stat. 710; amended Pub. L. 110–237, §1(a)(5), May 27, 2008, 122 Stat. 1557; Pub. L. 113–240, §6, Dec. 18, 2014, 128 Stat. 2854.)

#### **Editorial Notes**

#### Amendments

2014—Pub. L. 113–240, §6(1), inserted "and surveillance" after "quality" in section catchline.

Subsec. (a). Pub. L. 113–240, §6(2)(A), substituted "and taking into consideration the expertise of the Advisory Committee" for "and in consultation with the Advisory Committee" in introductory provisions.

Subsec. (a)(1). Pub. L. 113–240, §6(2)(B), inserted "timeliness for processing such tests," after "newborn-screening tests,".

Subsec. (b). Pub. L. 113–240, §6(3), added subsec. (b) and struck out former subsec. (b). Prior to amendment, text read as follows: "For the purpose of carrying out this section, there are authorized to be appropriated $5,000,000 for fiscal year 2009, $5,062,500 for fiscal year 2010, $5,125,000 for fiscal year 2011, $5,187,500 for fiscal year 2012, and $5,250,000 for fiscal year 2013."

2008—Subsec. (b). Pub. L. 110–237 substituted "2009, $5,062,500 for fiscal year 2010, $5,125,000 for fiscal year 2011, $5,187,500 for fiscal year 2012, and $5,250,000 for fiscal year 2013." for "2008, $5,062,500 for fiscal year 2009, $5,125,000 for fiscal year 2010, $5,187,500 for fiscal year 2011, and $5,250,000 for fiscal year 2012."
#### § 224.44 Right to administrative offset.

The amount of any penalty or assessment which has become final, or for which a judgment has been entered under § 224.42 or § 224.43, or any amount agreed upon in a compromise or settlement under § 224.46, may be collected by administrative offset under 31 U.S.C. 3716, except that an administrative offset may not be made under the subsection against a refund of an overpayment of Federal taxes, then or later owning by the United States to the defendant.
### §300x–21. Formula grants to States

#### (a) In general

For the purpose described in subsection (b), the Secretary, acting through the Center for Substance Abuse Treatment, shall make an allotment each fiscal year for each State in an amount determined in accordance with section 300x–33 of this title. The Secretary shall make a grant to the State of the allotment made for the State for the fiscal year if the State submits to the Secretary an application in accordance with section 300x–32 of this title.

#### (b) Authorized activities

A funding agreement for a grant under subsection (a) is that, subject to section 300x–31 of this title, the State involved will expend the grant only for the purpose of carrying out the plan developed in accordance with section 300x–32(b) of this title and for planning, carrying out, and evaluating activities to prevent, treat, and provide recovery support services for substance use disorders and for related activities authorized in section 300x–24 of this title.

(July 1, 1944, ch. 373, title XIX, §1921, as added Pub. L. 102–321, title II, §202, July 10, 1992, 106 Stat. 388; amended Pub. L. 114–255, div. B, title VIII, §8002(a), Dec. 13, 2016, 130 Stat. 1229; Pub. L. 117–328, div. FF, title I, §1242, Dec. 29, 2022, 136 Stat. 5678.)

#### **Editorial Notes**

#### Prior Provisions

A prior section 1921 of act July 1, 1944, was classified to section 300x–9 of this title prior to repeal by Pub. L. 102–321.

Another prior section 1921 of act July 1, 1944, was classified to section 300y of this title prior to repeal by Pub. L. 100–690.

#### Amendments

2022—Subsec. (b). Pub. L. 117–328 substituted "activities to prevent, treat, and provide recovery support services for substance use disorders" for "activities to prevent and treat substance use disorders".

2016—Subsec. (b). Pub. L. 114–255 inserted "carrying out the plan developed in accordance with section 300x–32(b) of this title and for" after "for the purpose of" and substituted "use disorders" for "abuse".
MEMORANDUM

DATE: May 21, 2015

TO: Clean Power Plan for Existing Power Plants; Docket ID: OAR-2013-0602

FROM: Reynaldo Forte, EPA Office of Air and Radiation

SUBJECT: May 21, 2015, meeting with Los Angeles Department of Water and Power regarding 

comments submitted on the Proposed Clean Power Plan for Existing Power Plants

SUMMARY

A meeting was held between EPA and the attendees listed below on May 21, 2015 to discuss the 

external stakeholders’ comments related to gross generation reporting vs. net generation reporting as 

submitted to the docket for the Proposed Clean Power Plan. The Proposed Clean Power Plan for Existing 

Power Plants was proposed on June 2, 2014 and published in the Federal Register on June 18, 2014.

ATTENDEES

External Stakeholders

Cindy Parsons, LADWP

Robert Hodel, LADWP

Leizl Lontok, LADWP

Jodean Giese, LADWP

EPA

Reynaldo Forte, EPA HQ

Colin Boswell, EPA HQ

Jeremy Schreifels, EPA HQ

Charles Frushour, EPA HQ
#### § 230.10 Payment to USAID of excess amounts received by a Noteholder.

If a Noteholder shall, as a result of USAID paying compensation under this Guarantee, receive an excess payment, it shall refund the excess to USAID.
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          JUN-30-1998
<PERIOD-END>                               DEC-31-1997
<CASH>                                             139
<SECURITIES>                                         0
<RECEIVABLES>                                   48,450
<ALLOWANCES>                                         0
<INVENTORY>                                     21,348
<CURRENT-ASSETS>                                85,656
<PP&E>                                         231,870
<DEPRECIATION>                                  36,886
<TOTAL-ASSETS>                                 514,440
<CURRENT-LIABILITIES>                           76,827
<BONDS>                                        225,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         4,162
<OTHER-SE>                                      53,703
<TOTAL-LIABILITY-AND-EQUITY>                   514,440
<SALES>                                        276,548
<TOTAL-REVENUES>                               276,548
<CGS>                                          235,840
<TOTAL-COSTS>                                  254,483
<OTHER-EXPENSES>                                     4
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              17,839
<INCOME-PRETAX>                                  4,222
<INCOME-TAX>                                     2,432
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     1,790
<EPS-PRIMARY>                                      .43
<EPS-DILUTED>                                        0
        

</TABLE>
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          JUL-31-1999
<PERIOD-START>                             AUG-01-1998
<PERIOD-END>                               APR-30-1999
<CASH>                                           9,767
<SECURITIES>                                    15,682
<RECEIVABLES>                                    3,601
<ALLOWANCES>                                       576
<INVENTORY>                                        207
<CURRENT-ASSETS>                                29,192
<PP&E>                                           5,282
<DEPRECIATION>                                   2,413
<TOTAL-ASSETS>                                  33,740
<CURRENT-LIABILITIES>                            6,213
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            13
<OTHER-SE>                                      27,514
<TOTAL-LIABILITY-AND-EQUITY>                    33,740
<SALES>                                              0
<TOTAL-REVENUES>                                14,329
<CGS>                                            1,574
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                17,859
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                (2,334)
<INCOME-TAX>                                     (591)
<INCOME-CONTINUING>                            (2,925)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (2,925)
<EPS-BASIC>                                   (0.23)
<EPS-DILUTED>                                   (0.23)


</TABLE>
NOT FOR PUBLICATION

UNITED STATES COURT OF APPEALS

FOR THE NINTH CIRCUIT

ANDREW STEVEN STRONG, 

Plaintiff-Appellant, 

 v. 

KYLE PETTENGELL, Tempe Police 

Officer #20942, 

Defendant-Appellee.

No. 19-15249 

D.C. No. 2:18-cv-03137-DLR-JZB 

MEMORANDUM*

Appeal from the United States District Court

for the District of Arizona

Douglas L. Rayes, District Judge, Presiding

Submitted June 2, 2020**

Before: LEAVY, PAEZ, and BENNETT, Circuit Judges.

Andrew Steven Strong appeals from the district court’s judgment dismissing 

his 42 U.S.C. § 1983 action alleging an excessive force claim. We have 

jurisdiction under 28 U.S.C. § 1291. We review de novo the district court’s 

dismissal under 28 U.S.C. § 1915A. Resnick v. Hayes, 213 F.3d 443, 447 (9th Cir. 

* This disposition is not appropriate for publication and is not precedent 

except as provided by Ninth Circuit Rule 36-3.

** The panel unanimously concludes this case is suitable for decision 

without oral argument. See Fed. R. App. P. 34(a)(2).

FILED

JUN 9 2020

MOLLY C. DWYER, CLERK

U.S. COURT OF APPEALS
 2 19-15249 

2000). We vacate and remand.

The district court dismissed Strong’s action after finding that success on 

Strong’s excessive force claim would necessarily imply the invalidity of his 

conviction for resisting arrest, relying on Heck v. Humphrey, 512 U.S. 477 (1994),

and taking judicial notice of the fact that Strong pled guilty to resisting arrest with 

physical force. However, it is not clear from the face of the complaint or the fact 

of his guilty plea that his excessive force claim would necessarily call into question 

the validity of his conviction, because the specific factual basis for his guilty plea 

is not in the record. See Reese v. County of Sacramento, 888 F.3d 1030, 1046 (9th 

Cir. 2018) (holding that without the specific factual basis for plaintiff’s prior 

conviction for drawing, exhibiting, or using a firearm or deadly weapon, the court 

could not determine if plaintiff’s excessive force claim would call into question the 

validity of the conviction); Hooper v. City of San Diego, 629 F.3d 1127, 1133-34

(9th Cir. 2011) (explaining that a plaintiff’s claim that an arresting officer used 

excessive force may coexist with a conviction for resisting a lawful arrest, when 

the conviction and the excessive force claim are based on different actions). We 

vacate the district court’s judgment and remand for further proceedings.

VACATED AND REMANDED.
Medicine Bow

+--+

{SWEETWATER
CARBON

(9) Avoidance of Domestic Sheep Grazing 010 20 40 60 80 100
Kilometers
0 5 10 20 30 40 50
|
Miles

Map 2-3
Domestic Sheep
Avoidance Areas

NO WARRANTY IS MADE BY THE BLM FOR USE OF THE DATA FOR PURPOSES NOT INTENDED BY BLM
### §285f–4. Microbicide research and development

The Director of the Institute, acting through the head of the Division of AIDS, shall, consistent with the peer-review process of the National Institutes of Health, carry out research on, and development of, safe and effective methods for use by women to prevent the transmission of the human immunodeficiency virus, which may include microbicides.

(July 1, 1944, ch. 373, title IV, §447C, as added Pub. L. 110–293, title II, §203(c), July 30, 2008, 122 Stat. 2941.)
CERTIFICATION PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
                            (18 U.S.C. SECTION 1350)


     In connection with the accompanying  Quarterly Report of Internet Infinity,
Inc.  (the  "Company")  on Form 10-QSB for the quarter  ended June 30, 2006 (the
"Report"),  I, Roger  Casas,  Chief  Executive  Officer of the  Company,  hereby
certify that to my knowledge:

     (1) The Report fully complies with the requirements of Section 15(d) of the
Securities Exchange Act of 1934 (15 U.S.C. ss.78o(d)); and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
material  respects,  the  financial  condition  and results of operations of the
Company.

Dated:  August 14, 2006

                                                          /s/ Roger Casas
                                                         -----------------------
                                                         Roger Casas
                                                         Chief Executive Officer


     The above  certification is furnished solely pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 (18 U.S.C. ss.1350) and is not being filed as part of
the Form 10-QSB or as a separate disclosure document.











                                                                      Exhibit 32
```

[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2451 Introduced in House (IH)]

109th CONGRESS
  1st Session
                                H. R. 2451

     To extend the temporary suspension of duty on Baysilone Fluid.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                              May 18, 2005

  Mr. Murphy introduced the following bill; which was referred to the 
                      Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
     To extend the temporary suspension of duty on Baysilone Fluid.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. BAYSILONE FLUID.

    (a) In General.--Heading 9902.04.03 of the Harmonized Tariff 
Schedule of the United States (relating to Baysilone Fluid) is amended 
by striking ``12/31/2006'' and inserting ``12/31/2009''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of enactment of this Act.
                                 <all>
```
### §256f. Designated dental health professional shortage area

In this subpart, the term "designated dental health professional shortage area" means an area, population group, or facility that is designated by the Secretary as a dental health professional shortage area under section 254e of this title or designated by the applicable State as having a dental health professional shortage.

(July 1, 1944, ch. 373, title III, §340F, as added Pub. L. 107–251, title IV, §403, Oct. 26, 2002, 116 Stat. 1660.)
Exhibit 10.26


 


Creditor Claims and Debt
Assignment Agreement


 


This CLAIMS AND DEBT ASSIGNMENT
AGREEMENT (this “Agreement”) is made on June 25, 2010 by and among:


 


Party A: International Petroleum
Services Corporation Limited


 


Party B:   Liu Qingzeng (PRC ID Card No.:
132903195912096511)


 


Party C:  Tianjin New Highland Science Development Co., Ltd.


 


WHEREAS,


 


(1)  Party B has creditor
claims against Party A in the amount of HKD242,613,954;


 


(2)  Party C has creditor
claims against Party B in the amount of RMB156,785,948;


 


NOW, THEREFORE, upon friendly
consultations, the parties agree as follows in respect of the foregoing
creditor claims and debts:


 


1. 
Party B shall waive an amount of HKD179,579,489 out of its forgoing
creditor claims against Party A.


 


2. 
In consideration of Paragraph 1 above, Party B shall assign its debt in
respect of Party C to Party A, which shall be responsible for repaying such
RMB156,785,948 to Party C.


 


3. 
As from the effective date hereof, the balance of Party B’s creditor
claims against Party A shall be in the amount of HKD63,034,465 only and Party B
shall become clear and free of any debt to Party C.


 


4. This Agreement shall be executed
in three copies and each party shall hold one copy. This Agreement shall become
effective as from the date of execution and sealing.


 


(No Operative Text Below)


 

















 


(Signature Page)


 


IN
WITNESS WHEREOF, the parties have each duly executed this Agreement as of the
date first above written.


 


 


Party A


 


International Petroleum Services
Corporation Limited (Seal)


 


	
  By:

  	
  /s/
  Liu Qingzeng

  	
   

  
	
   

  	
  (Authorized Representative)

  	
   

  



 


 


Party B


 


	
  By:

  	
  /s/
  Liu Qingzeng

  	
   

  
	
   

  	
  (Liu Qingzeng)

  	
   

  



 


 


Party C


 


Tianjin New Highland Science
Development Co., Ltd. (Seal)


 


	
  By:

  	
  /s/
  Xin Guoqiang

  	
   

  
	
   

  	
  (Authorized Representative)

  	
   

  



 


2
#### § 230.12 Prosecution of claims.

After payment by USAID to an Applicant hereunder, USAID shall have exclusive power to prosecute all claims related to rights to receive payments under the Eligible Notes to which it is thereby subrogated. If a Noteholder continues to have an interest in the outstanding Eligible Notes, such a Noteholder and USAID shall consult with each other with respect to their respective interests in such Eligible Notes and the manner of and responsibility for prosecuting claims.